Inhibrx Biosciences Inc. (INBX)
NASDAQ·Healthcare·Biotechnology
$79.60
-0.10%
Mkt Cap $1.17B
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$325.00
Range $325.00 – $325.00
Implied Upside
+308.3%
Consensus $325.00 vs current $79.60
NASDAQ·Healthcare·Biotechnology
$79.60
-0.10%
Mkt Cap $1.17B
No recent rating data.
Price Target (1 analysts)
$325.00
Range $325.00 – $325.00
+308.3%
Consensus $325.00 vs current $79.60